Hantz Financial Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.86M Sell
9,231
-36
-0.4% -$20.2K 0.07% 191
2026
Q1
$5.21M Sell
9,267
-17,350
-65% -$11.1M 0.08% 175
2025
Q4
$18M Sell
26,617
-2,148
-7% -$1.46M 0.27% 57
2025
Q3
$18.4M Sell
28,765
-3,876
-12% -$2.35M 0.28% 61
2025
Q2
$17.5M Buy
32,641
+24,633
+308% +$11.8M 0.28% 67
2025
Q1
$3.36M Buy
8,008
+270
+3% +$117K 0.06% 253
2024
Q4
$3.2M Buy
7,738
+800
+12% +$351K 0.06% 260
2024
Q3
$3.5M Sell
6,938
-113
-2% -$54.9K 0.06% 254
2024
Q2
$3.44M Buy
7,051
+1,407
+25% +$706K 0.07% 253
2024
Q1
$3.05M Sell
5,644
-349
-6% -$191K 0.06% 276
2023
Q4
$3.33M Sell
5,993
-320
-5% -$150K 0.07% 270
2023
Q3
$2.76M Sell
6,313
-13
-0.2% -$6.48K 0.07% 266
2023
Q2
$3.18M Sell
6,326
-97
-2% -$46.5K 0.08% 253
2023
Q1
$3.21M Buy
6,423
+465
+8% +$223K 0.09% 242
2022
Q4
$2.43M Buy
5,958
+5,932
+22,815% +$2.3M 0.07% 265
2022
Q3
$8K Sell
26
-27
-51% -$9.92K ﹤0.01% 776
2022
Q2
$19K Sell
53
-226
-81% -$92.2K ﹤0.01% 668
2022
Q1
$153K Sell
279
-995
-78% -$523K ﹤0.01% 541
2021
Q4
$839K Sell
1,274
-58
-4% -$36.4K 0.02% 388
2021
Q3
$828K Sell
1,332
-38
-3% -$25.5K 0.03% 359
2021
Q2
$865K Buy
1,370
+224
+20% +$124K 0.03% 339
2021
Q1
$561K Buy
1,146
+289
+34% +$145K 0.02% 355
2020
Q4
$428K Buy
857
+616
+256% +$276K 0.02% 341
2020
Q3
$95K Buy
+241
New +$89.1K ﹤0.01% 437

Other funds holding IDXX

Hantz Financial Services's IDXX Position: Q2 2026 in Review

Hantz Financial Services reduced its Idexx Laboratories (IDXX) stake by 0.39% in Q2 2026, selling an estimated $20.2K and leaving 9,231 shares worth $4.86M. The position accounts for 0.07% of the portfolio, ranked #191.

Hantz Financial Services first reported a position in IDXX in Q3 2020 and has held it in 24 quarters since. The position peaked at $18.4M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Hantz Financial Services held 9,231 shares of Idexx Laboratories worth $4.86M as of Q2 2026.
  • Hantz Financial Services sold 36 Idexx Laboratories shares in Q2 2026, an estimated $20.2K.
  • Idexx Laboratories made up 0.07% of Hantz Financial Services's portfolio in Q2 2026, its #191 holding.
  • Hantz Financial Services first reported a position in Idexx Laboratories in Q3 2020 and has held it in 24 quarters since.
  • Hantz Financial Services's Idexx Laboratories position peaked at $18.4M in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.